Physician profile
John K Stokes
NPI 1245390095
$522,315.14
in general payments reported to CMS, 2019-2025
13 companies · $48K in 2025
The $48K reported for 2025 was more than what 95% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137K · 2020: $78K · 2021: $76K · 2022: $80K · 2023: $60K · 2024: $44K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $151K · Food and Beverage: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $150,767.88 |
| Food and Beverage | $1,045.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $519,517.32 | 2019-2025 | Tilock, Binary, Apache |
| Surgalign Spine Technologies, INC. | $1,241.77 | 2022 | |
| Stryker Corporation | $329.00 | 2020-2021 | |
| Spinal Elements, INC. | $272.82 | 2023 | |
| Globus Medical, INC. | $269.39 | 2021-2025 | Creo, Canopy |
| Providence Medical Technology, INC. | $199.29 | 2025 | |
| Zimvie INC. | $144.40 | 2024 | |
| Medtronic, INC. | $93.15 | 2022-2025 | Unid_pass, N/A |
| Curiteva, INC. | $88.00 | 2020 | |
| Depuy Synthes Sales INC. | $74.07 | 2023 | Teligen |
| Orthofix Medical, INC. | $63.53 | 2023-2025 | Cervical-Stim, Newbridge, M6-C |
| Medtronic USA, INC. | $22.40 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$412,825.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.